Delivery Order SPE2DB24D3014-SPE2DB25FKTKX
Award Date
5/14/25
Potential Completion Date
6/5/25
Potential Value
$6.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESBRIET 267 MG TABLET 270S, a pharmaceutical product, with a ceiling value of $3,425.95 and a period of performance through May 9, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed-price contract is for the supply of ESBRIET 267 MG TABLET 270S, a prescription medication. The contract has an ultimate completion date of May 28, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.95, is for the delivery of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of April 18, 2025, and is a firm fixed-price contract. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed-price contract is for the supply of ESBRIET 267 MG TABLET 270S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ESBRIET 801 MG TABLET 90S. The contract has a firm fixed price of $3,425.95 and a period of performance through June 5, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.95, is for the delivery of 4568189215 ESBRIET 267 MG TABLET 270S, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside delivery order with a performance period ending on May 30, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $3,311.50 firm fixed price contract is for the delivery of ESBRIET 801 MG TABLET 90S pharmaceutical product. The contract has an ultimate completion date of June 12, 2024 and was awarded on May 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $3,425.95, is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed-price contract with a performance period ending on March 3, 2025. The award date was February 7, 2025, and there was no set-aside designation used. AmerisourceBergen Drug Corp is the prime contractor,...
This is a federal delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 firm fixed-price contract is for the delivery of ESBRIET 801 MG TABLET 90S, a medical product, with a period of performance through January 30, 2025. This order is placed against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.95, is for the supply of ESBRIET 267 MG TABLET 270S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...